NATIXIS - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 67 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
NATIXIS ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,168
-36.2%
8000.0%0.00%
Q2 2023$1,832
-97.5%
800
-97.1%
0.00%
Q2 2021$74,000
+45.1%
27,900
+69.1%
0.00%
Q1 2021$51,00016,5000.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,746,0001.82%
Telemetry Investments, L.L.C. 263,975$705,0000.97%
CHI Advisors LLC 719,132$1,920,0000.45%
BVF INC/IL 3,678,626$9,822,0000.37%
EcoR1 Capital, LLC 3,579,377$9,557,0000.36%
Orbimed Advisors 8,053,298$21,502,0000.22%
Stonepine Capital Management, LLC 46,886$125,0000.06%
Ikarian Capital, LLC 100,000$267,0000.02%
ALGERT GLOBAL LLC 19,737$53,0000.02%
Windsor Creek Advisors, LLC 14,786$39,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders